Evidence map›Paper›PMID 26572681›Full record

ArticleBMC research notes2015

Transmembrane transporter expression regulated by the glucosylceramide pathway in Cryptococcus neoformans.

Arpita Singh, Antonella Rella, John Schwacke, Caterina Vacchi-Suzzi, Chiara Luberto, Maurizio Del Poeta

Open access · goldAbstract read
In one paragraph

Article in BMC research notes, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Arpita SinghDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, 29425, USA. arpitamanu@gmail.com.
Antonella RellaDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, 29425, USA. antonella.rella@stonybrook.edu.
John SchwackeDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, 29425, USA. jschwack@gmail.com.
Caterina Vacchi-SuzziDepartment of Preventive Medicine, University of Stony Brook, Stony Brook, NY, 11794, USA. caterina.vacchi-suzzi@stonybrookmedicine.edu.
Chiara LubertoDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, 29425, USA. chiara.luberto@stonybrook.edu.
Maurizio Del PoetaDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, 29425, USA. maurizio.delpoeta@stonybrook.edu.
Medical University of South Carolina · USStony Brook University · US

Funding

Sphingolipid-mediated fungal pathogenesisR01AI056168 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI DEL POETA, MAURIZIO · 2004 to 2013
$2.7M
Role of phagocytosis in pathogenesis of Cryptococcus neorformansR01AI071142 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI DEL POETA, MAURIZIO · 2008 to 2012
$1.7M
Identification of new compounds against fungal microbesR21AI100631 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI DEL POETA, MAURIZIO · 2013 to 2014
$425k
Host sphingolipids and fungal infectionR56AI087541 · NIAID · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HAMA, HIROKO · 2011 to 2011
$383k
NIAID NIH HHS AI100631NIAID NIH HHS AI56168NIAID NIH HHS AI71142NIAID NIH HHS AI87541NIAID NIH HHS R01 AI056168NIAID NIH HHS R01 AI071142NIAID NIH HHS R21 AI100631NIAID NIH HHS R56 AI087541
6 · The paper itself

Abstract

backgroundThe sphingolipid glucosylceramide (GlcCer) and factors involved in the fungal GlcCer pathways were shown earlier to be an integral part of fungal virulence, especially in fungal replication at 37 °C, in neutral/alkaline pH and 5 % CO2 environments (e.g. alveolar spaces). Two mutants, ∆gcs 1 lacking glucosylceramide synthase 1 gene (GCS1) which catalyzes the formation of sphingolipid GlcCer from the C9-methyl ceramide and ∆smt1 lacking sphingolipid C9 methyltransferase gene (SMT1), which adds a methyl group to position nine of the sphingosine backbone of ceramide, of this pathway were attenuated in virulence and have a growth defect at the above-mentioned conditions. These mutants with either no or structurally modified GlcCer located on the cell-membrane have reduced membrane rigidity, which may have altered not only the physical location of membrane proteins but also their expression, as the pathogen's mode of adaptation to changing need. Importantly, pathogens are known to adapt themselves to the changing host environments by altering their patterns of gene expression.

resultsBy transcriptional analysis of gene expression, we identified six genes whose expression was changed from their wild-type counterpart grown in the same conditions, i.e. they became either down regulated or up regulated in these two mutants. The microarray data was validated by real-time PCR, which confirmed their fold change in gene expression. All the six genes we identified, viz siderochrome-iron transporter (CNAG_02083), monosaccharide transporter (CNAG_05340), glucose transporter (CNAG_03772), membrane protein (CNAG_03912), membrane transport protein (CNAG_00539), and sugar transporter (CNAG_06963), are membrane-localized and have significantly altered gene expression levels. Therefore, we hypothesize that these genes function either independently or in tandem with a structurally modified cell wall/plasma membrane resulting from the modifications of the GlcCer pathway and thus possibly disrupt transmembrane signaling complex, which in turn contributes to cryptococcal osmotic, pH, ion homeostasis and its pathobiology.

conclusionSix genes identified from gene expression microarrays by gene set enrichment analysis and validated by RT-PCR, are membrane located and associated with the growth defect at neutral-alkaline pH due to the absence and or presence of a structurally modified GlcCer. They may be involved in the transmembrane signaling network in Cryptococcus neoformans, and therefore the pathobiology of the fungus in these conditions.

Indexed as

Cryptococcus neoformansGene Expression ProfilingGene Expression RegulationGlucosylceramidesMicroarray AnalysisSignal TransductionGlucosylceramides

Identifiers

PMID26572681
PMCPMC4647647
OpenAlexW2175479087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.